UCB China, a branch of UCB, a global biopharmaceutical company, signed an agreement with SIP on June 4 to set up an integrated intelligent pharmaceutical operation center in the park.

Shen Mi, member of the Standing Committee of CPC Suzhou Committee and secretary of the CPC SIP Working Committee, and Sandrine Dufour, executive vice president and chief financial officer at UCB, attended the signing ceremony.

UCB, headquartered in Brussels, Belgium, is globally renowned for its long-term commitment to discovering and developing treatments that aim to transform the lives of people living with neurological and immunological conditions, as well as rare diseases. The new project will be the first of its kind in China. It is expected to significantly improve UCB’s operation efficiency and service ability in the country.

June 5, 2026